117 related articles for article (PubMed ID: 23180061)
21. Retraction notice to Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery: Am J Obstet Gynecol 2000;182:13-16.
Fujii Y; Tanaka H; Somekawa Y
Am J Obstet Gynecol; 2018 Jun; 218(6):621. PubMed ID: 29793574
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of prevention of postoperative nausea and vomiting: randomised controlled trials by Fujii et al. compared with other authors.
Carlisle JB
Anaesthesia; 2012 Oct; 67(10):1076-90. PubMed ID: 22734848
[TBL] [Abstract][Full Text] [Related]
23. Retraction: 'Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy' by Dr Yoshitaka Fujii.
Laryngoscope; 2017 Sep; 127(9):E335. PubMed ID: 28833223
[No Abstract] [Full Text] [Related]
24. Expression of Concern: "Prevention of Nausea and Vomiting After Middle Ear Surgery: Granisetron Versus Ramosetron," "Prevention of Vomiting After Tonsillectomy in Children: Granisetron Versus Ramosetron," and "Granisetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting After Thyroidectomy" by Dr Yoshitaka Fujii.
Laryngoscope; 2016 Dec; 126(12):E386. PubMed ID: 27650869
[No Abstract] [Full Text] [Related]
25. Retraction: 'Prevention of vomiting after tonsillectomy in children: Granisetron versus ramosetron' by Dr Yoshitaka Fujii.
Laryngoscope; 2017 Sep; 127(9):E334. PubMed ID: 28833224
[No Abstract] [Full Text] [Related]
26. Systemic metoclopramide to prevent postoperative nausea and vomiting: a meta-analysis without Fujii's studies.
De Oliveira GS; Castro-Alves LJ; Chang R; Yaghmour E; McCarthy RJ
Br J Anaesth; 2012 Nov; 109(5):688-97. PubMed ID: 23015617
[TBL] [Abstract][Full Text] [Related]
27. Retraction: 'Prevention of nausea and vomiting after middle ear surgery: Granisetron versus ramosetron' by Dr Yoshitaka Fujii.
Laryngoscope; 2017 Sep; 127(9):E333. PubMed ID: 28833222
[No Abstract] [Full Text] [Related]
28. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
29. Request for determination regarding papers published by Dr Yoshitaka Fujii.
Br J Surg; 2012 Oct; 99(10):1321. PubMed ID: 22961508
[No Abstract] [Full Text] [Related]
30. Retraction note: Notice of formal retraction of articles by Dr. Yoshitaka Fujii.
Hirota K
J Anesth; 2013 Apr; 27(2):322. PubMed ID: 23455701
[No Abstract] [Full Text] [Related]
31. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
Yarker YE; McTavish D
Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic antiemetic efficacy of granisetron in patients with and without previous postoperative emesis.
Fujii Y; Tanaka H; Toyooka H
Can J Anaesth; 1997 Mar; 44(3):273-7. PubMed ID: 9067046
[TBL] [Abstract][Full Text] [Related]
33. Retraction: Nucleophagy in Human Disease: Beyond the Physiological Role. [Tohoku J. Exp. Med., 2018, 244 (1), 75-81. doi: 10.1620/tjem.244.75. Review.].
Tohoku J Exp Med; 2018 Feb; 244(2):175. PubMed ID: 29467341
[TBL] [Abstract][Full Text] [Related]
34. Expression of Concern: 'Reduction of Postoperative Nausea and Vomiting and Analgesic Requirement with Dexamethasone in Women Undergoing General Anesthesia for Mastectomy' by Dr. Yoshitaka Fujii.
Breast J; 2016 May; 22(3):371. PubMed ID: 27124773
[No Abstract] [Full Text] [Related]
35. Retraction Note to: Preference for immediate reinforcement over delayed reinforcement: relation between delay discounting and health behavior.
J Behav Med; 2015 Oct; 38(5):835. PubMed ID: 26613108
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
37. Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
Gralla RJ; Navari RM; Hesketh PJ; Popovic W; Strupp J; Noy J; Einhorn L; Ettinger D; Bushnell W; Friedman C
J Clin Oncol; 1998 Apr; 16(4):1568-73. PubMed ID: 9552067
[TBL] [Abstract][Full Text] [Related]
38. Retraction of articles written by Dr. Yoshitaka Fujii.
Miller DR
Can J Anaesth; 2012 Dec; 59(12):1081-8. PubMed ID: 23055039
[No Abstract] [Full Text] [Related]
39. Editor's note: notice of retraction.
Shafer SL
Anesth Analg; 2014 Nov; 119(5):1225. PubMed ID: 25329035
[TBL] [Abstract][Full Text] [Related]
40. Retraction notice to "Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus" [Br J Anaesth 2003; 90: 480-486].
Saitoh Y; Kaneda K; Hattori H; Nakajima H; Murakawa M
Br J Anaesth; 2019 Jan; 122(1):156. PubMed ID: 30579400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
